Russell Investments Group’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$270K Buy
14,058
+591
+4% +$11.8K ﹤0.01% 2746
2025
Q4
$222K Sell
13,467
-332
-2% -$5.6K ﹤0.01% 2810
2025
Q3
$200K Buy
13,799
+11,241
+439% +$162K ﹤0.01% 2812
2025
Q2
$35.8K Sell
2,558
-83
-3% -$1.17K ﹤0.01% 3060
2025
Q1
$35.9K Sell
2,641
-19,475
-88% -$373K ﹤0.01% 2978
2024
Q4
$451K Buy
22,116
+142
+0.6% +$3.63K ﹤0.01% 2302
2024
Q3
$640K Sell
21,974
-940
-4% -$23.3K ﹤0.01% 2196
2024
Q2
$532K Sell
22,914
-62,714
-73% -$1.2M ﹤0.01% 2175
2024
Q1
$1.76M Sell
85,628
-25,845
-23% -$486K ﹤0.01% 1711
2023
Q4
$2.39M Sell
111,473
-2,585
-2% -$51.2K ﹤0.01% 1517
2023
Q3
$2.35M Buy
114,058
+7,244
+7% +$184K ﹤0.01% 1456
2023
Q2
$3.15M Buy
106,814
+24,519
+30% +$689K 0.01% 1303
2023
Q1
$1.9M Sell
82,295
-17,078
-17% -$470K ﹤0.01% 1618
2022
Q4
$2.76M Sell
99,373
-7,488
-7% -$223K 0.01% 1389
2022
Q3
$3.28M Buy
106,861
+18,631
+21% +$606K 0.01% 1290
2022
Q2
$2.6M Buy
88,230
+36,710
+71% +$962K 0.01% 1447
2022
Q1
$1.66M Sell
51,520
-14,601
-22% -$502K ﹤0.01% 1729
2021
Q4
$2.95M Buy
66,121
+770
+1% +$36.5K ﹤0.01% 1586
2021
Q3
$3.28M Buy
65,351
+1,594
+3% +$89.8K 0.01% 1506
2021
Q2
$4.99M Buy
63,757
+15,791
+33% +$977K 0.01% 1354
2021
Q1
$2.73M Sell
47,966
-32,129
-40% -$2.15M ﹤0.01% 1709
2020
Q4
$6.71M Buy
80,095
+25,496
+47% +$1.54M 0.01% 1079
2020
Q3
$1.96M Hold
54,599
﹤0.01% 1703
2020
Q2
$1.32M Sell
54,599
-17,130
-24% -$403K ﹤0.01% 1886
2020
Q1
$1.25M Sell
71,729
-45,190
-39% -$943K ﹤0.01% 1732
2019
Q4
$2.04M Buy
116,919
+47,796
+69% +$796K ﹤0.01% 1731
2019
Q3
$1.06M Buy
69,123
+33,583
+94% +$642K ﹤0.01% 1980
2019
Q2
$736K Buy
35,540
+9,650
+37% +$216K ﹤0.01% 2116
2019
Q1
$601K Buy
25,890
+9,094
+54% +$190K ﹤0.01% 2282
2018
Q4
$347K Buy
+16,796
New +$305K ﹤0.01% 2435

Other funds holding DNLI